Insight happens when data meets expertise

We are a pricing and market access consultancy that combines business intelligence data and human expertise to help pharma companies get products to market.
squares-big-pink
branches-big-green
branches-small-green
Consulting

The critical support you need to develop a successful value assessment and launch strategy

squares-small-pink-framed
Data Tools

Cloud-based apps for rapid business intelligence, KPI tracking, access and evidence planning

Our game-changing approach opens the door to the insights you need.

Our approach

They say nothing lasts forever. Once upon a time, you worked hard creating the best opportunities for your products. You sought the highest potential price, the fullest reimbursement, and the widest access.

 

Today, we’re living in a very different world. Budgets are being squeezed. Payer expectations are shifting. That’s why we believe the only way to stay ahead is to adapt.

 

Our hybrid approach to pricing and market access brings data and expertise together, combining proven consultancy services with our own in-house digital tools. After all, insights only happen when data and expertise meet.

Our game-changing approach opens the door to the insights you need.

What our clients are saying

  • quotes

    The Access Infinity team are both strategic and detailed orientated… something that’s not easy to find

    Ana Cespedes
    COO, International AIDS Vaccine Initiative, formerly SVP and Head of Global Market Access and Pricing, Merck
  • quotes

    Access Infinity is one of the few vendors that I have worked with that has deep content area expertise on access and related issues world over

    Anuja Roy
    Franchise Director, Market Access, Haematology, Novartis
  • quotes

    Access Infinity provided excellent in-depth insights and guidance in key global markets. I’ve been very pleased with their responsiveness and the quality of work

    Kevin La Wall
    Commercial Director, Infectious Diseases, GSK

You're in good company

We have Preferred Vendor Status and MSAs with some of the

world’s most successful pharma companies

The numbers don't lie

0%

Year-on-year growth

0%

Win rate

0

Number of projects

0

Countries in which we’ve conducted payer research in the last 5 years